Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Burden of respiratory syncytial virus infection in young children.

Resch B.

World J Clin Pediatr. 2012 Oct 8;1(3):8-12. doi: 10.5409/wjcp.v1.i3.8. eCollection 2012 Oct 8.

2.

Host and environmental factors influencing respiratory secretion of pro-wheezing biomarkers in preterm children.

Matías V, San Feliciano L, Fernández JE, Lapeña S, Garrido E, Ardura J, Soga MJ, Aragón MP, Remesal A, Benito F, Andrés J, Centeno F, Marugán V, Bachiller R, Bermejo-Martin JF.

Pediatr Allergy Immunol. 2012 Aug;23(5):441-7. doi: 10.1111/j.1399-3038.2012.01269.x. Epub 2012 May 3.

PMID:
22554061
3.

Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic review.

Prescott WA Jr, Doloresco F, Brown J, Paladino JA.

Pharmacoeconomics. 2010;28(4):279-93. doi: 10.2165/11531860-000000000-00000. Review.

PMID:
20131925
4.

Respiratory syncytial virus infection and recurrent wheezing: what next?

Puddu M, Fanos V.

J Chemother. 2007 Oct;19 Suppl 2:8-11. Review.

PMID:
18073170
5.

Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease.

Elhassan NO, Sorbero ME, Hall CB, Stevens TP, Dick AW.

Arch Pediatr Adolesc Med. 2006 Oct;160(10):1070-6.

PMID:
17018467
6.

Respiratory syncytial virus infections: old challenges and new opportunities.

Mejías A, Chávez-Bueno S, Jafri HS, Ramilo O.

Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S189-96, discussion S196-7. Review.

PMID:
16378045
7.

Systematic review of the biology and medical management of respiratory syncytial virus infection.

Black CP.

Respir Care. 2003 Mar;48(3):209-31; discussion 231-3. Review.

Supplemental Content

Loading ...
Support Center